- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Richard Umdenstock Addresses the Challenges That Institutions May Face With the Newly Insured
Richard Umdenstock, president and chief executive officer, American Hospital Association, says institutions may face a number of challenges as they absorb the newly insured.
Richard Umdenstock, president and chief executive officer, American Hospital Association, says institutions may face a number of challenges as they absorb the newly insured. First, they will need to ensure that patients are correctly utilizing services in the system. For instance, this means they are not waiting too long to seek care or using the emergency department as a first point of care. Next, he suggests that hospitals and other institutions will need the internal capacity—whether in staff numbers or physical space—to treat the volumes of patients seeking care. Finally, he suggests that collaborating with partners outside the hospital will be essential. Mr Umdenstock suggests that not everything has to happen at the hospital.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
